NBC Securities’s Caribou Biosciences CRBU Stock Holding History

NBC Securities’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$3	–	2124
2024 Q4	$3	Sell	2 -2,256	-100%	-$4.54K	﹤0.01%	1231
2024 Q3	$4K	Buy	+2,258	New	+$4.62K	﹤0.01%	1915

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NBC Securities's CRBU Position: Q1 2025 in Review

NBC Securities sold out of Caribou Biosciences (CRBU) in Q1 2025, closing a stake of 2 shares — an estimated $3 sold.

NBC Securities first reported a position in CRBU in Q3 2024 and held it in 2 quarters. The position peaked at $4K in Q3 2024. 131 funds tracked by Wall St. Rank hold CRBU as of Q1 2025.

NBC Securities reported no remaining Caribou Biosciences position as of Q1 2025 after selling out during the quarter.
NBC Securities sold 2 Caribou Biosciences shares in Q1 2025, an estimated $3.
NBC Securities first reported a position in Caribou Biosciences in Q3 2024 and held it in 2 quarters.
NBC Securities's Caribou Biosciences position peaked at $4K in Q3 2024.
131 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2025.

Based on NBC Securities's 13F filing for Q1 2025, filed 9 Apr 2025.